Max India gets nod to divest 85.17% stake in Pharmax Corporation

27 Jun 2019 Evaluate

Max India has received an approval for divestment of entire equity shareholding in its material subsidiary viz. Pharmax Corporation (Pharmax) (equivalent to 85.17% of Pharmax's total issued and paid-up equity share capital) to Max Estates, a wholly owned subsidiary of Max Ventures and Industries for an aggregate consideration of Rs 61.2 crore. The Board of Directors of the company at its meeting held on June 26, 2019 has considered and approved the same.

Max India is engaged in the business of investments and providing consultancy services to group companies. The company’s segments are Healthcare Business, Business Investments, Health Insurance, Senior Living and Others.

Max India-Amalgamat. Share Price

68.65 0.00 (0.00%)
11-Jun-2020 18:01 View Price Chart
Peers
Company Name CMP
Bajaj Finserv 1564.70
Paul Merchants 872.60
Data Infrastructure 148.00
IIFL Finance 470.60
Embassy Office Parks 353.24
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.